Esperion is the Lipid Management Company committed to developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated LDL-C.
2025/1/13 17:49:02
(ESPR:NASDAQ)
Analyst coverage
Streetwise Reports Articles